亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium.

作者
Imke Anne Maartje Ditters,Hidde H. Huidekoper,Michelle E. Kruijshaar,Dimitris Rizopoulos,Andreas Hahn,Tiziana Mongini,François Labarthe,M. Tardieu,Brigitte Chabrol,Anaïs Brassier,Rossella Parini,Giancarlo Parenti,Nadine A. M. E. van der Beek,Ans T. van der Ploeg,Johanna Maria Pieternel van den Hout
出处
期刊:The Lancet Child & Adolescent Health [Elsevier BV]
被引量:3
标识
DOI:10.1016/s2352-4642(21)00308-4
摘要

Background Enzyme replacement therapy (ERT) with alglucosidase alfa has been found to improve outcomes in patients with classic infantile Pompe disease, who without treatment typically die before the age of 1 year. Variable responses to the standard recommended dosage have led to alternative dosing strategies. We aimed to assess the effect of real-world ERT regimens on survival and walking ability in these patients. Methods In this observational cohort study, we obtained data collected as part of a collaborative study within the European Pompe Consortium on patients with classic infantile Pompe disease from France, Germany, Italy, and the Netherlands diagnosed between Oct 26, 1998 and March 8, 2019. Eligible patients had classic infantile Pompe disease with a disease onset and proven diagnosis before age 12 months, and a hypertrophic cardiomyopathy. A proven diagnosis of classic infantile Pompe disease was defined as a confirmed deficiency of α-glucosidase in leukocytes or lymphocytes, fibroblasts or muscle, or two pathogenic GAA variants in trans, or both. We collected data on demographics, GAA variants, ERT dosage, age at death, and walking ability. We analysed the effects of ERT dosage on survival and walking ability using Cox regression, Kaplan-Meier curves, and log-rank tests. Findings We included 124 patients with classic infantile Pompe disease, of whom 116 were treated with ERT (median age at start of treatment 3·3 months [IQR 1·8-5·0, range 0·03-11·8]). During follow-up (mean duration 60·1 months [SD 57·3]; n=115), 36 (31%) of 116 patients died. 39 different ERT dosing regimens were applied. Among the 64 patients who remained on the same dosage, 16 (52%) of 31 patients on the standard dosage (20 mg/kg every other week), 12 (80%) of 15 patients on an intermediate dosage (20 mg/kg per week or 40 mg/kg every other week), and 16 (89%) of 18 patients on the high dosage (40 mg/kg per week) were alive at last follow-up. Survival was significantly improved in the high dosage group compared with the standard dosage group (hazard ratio [HR] 0·17 [95% CI 0·04-0·76], p=0·02). No significant difference in survival was identified between the intermediate dosage group and the standard dosage group (HR 0·44 [0·13-1·51], p=0·19). Of the 86 patients who reached 18 months of age, 44 (51%) learned to walk. Ten (53%) of 19 patients on the standard dosage regimen, six (67%) of nine patients on intermediate dosage regimens, and 14 (93%) of 15 patients on high dosage regimens learnt to walk, but the differences between groups were not statistically significant. Interpretation Patients with classic infantile Pompe disease treated with the high ERT dosage of 40 mg/kg per week had significantly improved survival when compared with patients treated with the standard recommended ERT dosage of 20 mg/kg every other week. Based on these results, we suggest that the currently registered dosage should be reconsidered. Funding Prinses Beatrix Spierfonds and Wishdom Foundation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
程小柒完成签到 ,获得积分10
5秒前
7秒前
13秒前
Ghiocel完成签到,获得积分10
24秒前
30秒前
佟语雪完成签到,获得积分10
30秒前
轻松的惜芹应助喂喂采纳,获得10
34秒前
淳于如雪发布了新的文献求助10
37秒前
LLL完成签到 ,获得积分10
41秒前
yar应助淳于如雪采纳,获得10
42秒前
Koking关注了科研通微信公众号
47秒前
48秒前
淳于如雪完成签到,获得积分20
50秒前
lv发布了新的文献求助10
51秒前
我是老大应助吴嘉俊采纳,获得10
54秒前
55秒前
在水一方应助阿九采纳,获得10
1分钟前
1分钟前
ZT完成签到,获得积分10
1分钟前
搜集达人应助zhouleiwang采纳,获得10
1分钟前
吴嘉俊发布了新的文献求助10
1分钟前
仙人掌王朝完成签到,获得积分10
1分钟前
1分钟前
Hello应助zhouleiwang采纳,获得10
1分钟前
阿九完成签到,获得积分10
1分钟前
lllxxx完成签到 ,获得积分10
1分钟前
lv发布了新的文献求助10
1分钟前
冉亦完成签到,获得积分10
1分钟前
WGS完成签到,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
华仔应助科研通管家采纳,获得20
1分钟前
吉吉吉完成签到 ,获得积分10
1分钟前
1分钟前
阿九发布了新的文献求助10
1分钟前
大胆的小懒猪完成签到 ,获得积分10
1分钟前
111完成签到 ,获得积分10
1分钟前
1分钟前
yx_cheng应助001az采纳,获得30
1分钟前
1分钟前
miles完成签到,获得积分10
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990012
求助须知:如何正确求助?哪些是违规求助? 3532049
关于积分的说明 11256153
捐赠科研通 3270925
什么是DOI,文献DOI怎么找? 1805123
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216